The ACTA1 Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-mediated gene disruption model targeting the ACTA1 locus in the human A-549 cell line. This polyclonal knockout cell population carries heterogeneous edits that result in loss of skeletal muscle alpha-actin expression, providing a versatile loss-of-function system for studying ACTA1-dependent processes. Unlike clonal isolates, this polyclonal format preserves genetic diversity while enabling robust functional interrogation of ACTA1 in a cancer-relevant background.
The host A-549 cell line is a well-characterized epithelial model established from a 58-year-old Caucasian male with lung adenocarcinoma. Widely employed in oncology research, A-549 cells exhibit key features of adenocarcinoma, including aberrant cytoskeletal organization, altered adhesion properties, and dysregulated signaling pathways. Their adherent and migratory nature makes them a suitable platform for dissecting the contributions of actin isoforms to malignant cell behavior.
ACTA1 encodes skeletal muscle alpha-actin, a core component of the thin filament in sarcomeres, where it interacts with Tropomyosin, Troponin T, and Myosin heavy chain to mediate contraction. Transcription of ACTA1 is regulated by myogenic factors such as MYOD1, MYOG, MEF2C, and SRF, and its protein product is integrated into the sarcomeric apparatus via interactions with Alpha-actinin. Beyond muscle, alpha-actin participates in cytoskeletal remodeling and focal adhesion dynamics, interfacing with integrin signaling and calcium-dependent pathways that involve Troponin C and Myosin light chain kinase. Disruption of ACTA1 thus uncouples these signaling nodes, offering insights into actin isoform-specific functions.
In the A-549 lung adenocarcinoma context, ectopic or aberrant expression of muscle actins can influence cytoskeletal plasticity and metastatic potential. The ACTA1 polyclonal knockout model enables the dissection of its non-muscle roles, particularly in cell migration, adhesion, and actin filament turnover. This system allows investigation of how alpha-actin contributes to the malignant phenotype, including its impact on focal adhesion assembly, integrin-mediated signaling, and the structural rigidity of the actin network??processes often hijacked during tumor progression.
Researchers can employ these cells in a variety of assays to assess phenotypic consequences of ACTA1 loss. Western blotting and RT-qPCR confirm knockout efficiency and transcriptional changes, while immunofluorescence reveals alterations in actin cytoskeleton organization and focal adhesion distribution. Functional assays such as scratch-wound migration and adhesion to extracellular matrix substrates directly measure the impact on cell motility, enabling detailed mechanistic studies of actin isoform crosstalk and cytoskeletal dynamics in cancer. For further technical specifications or to request a quote, please contact Ascent Research.
